Close

Rating History for ResMed (RMD) by Citi

More Stocks Rated by Citi | Latest Ratings for RMD
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/28/2022 Mathieu Chevrier Downgrade Neutral
(Buy)		 N/A
(N/A)		 232.29
(183.42)		 -21.04% Details